NCT06791863

Brief Summary

This retrospective study included 1030 patients with clear cell renal cell carcinoma (ccRCC) who underwent radical or partial nephrectomy at Wuhan Union Hospital from 2014 to 2023.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,030

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
8.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 24, 2025

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

8.9 years

First QC Date

January 19, 2025

Last Update Submit

January 19, 2025

Conditions

ccRCC

Outcome Measures

Primary Outcomes (1)

  • overall survival (OS)

    5 years

Study Arms (2)

Cohort 1

The group with high area of body compositions (skeletal muscle, subcutaneous fat, subcutaneous fat or total fat)

Cohort 2

the group with low area of body compositions (skeletal muscle, subcutaneous fat, subcutaneous fat or total fat)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with clear cell renal cell carcinoma (ccRCC) who underwent radical or partial nephrectomy

You may qualify if:

  • primary clear cell renal cell carcinoma confirmed by histopathology;
  • patients≥18 years;
  • availability of preoperative abdominal computed tomography (CT) data;
  • patients with partial or radical nephrectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuhan Union Hospital

Wuhan, Hubei, 430000, China

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2025

First Posted

January 24, 2025

Study Start

November 1, 2014

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

January 24, 2025

Record last verified: 2025-01

Locations

CN(1)